Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis - the effect of sex, Kellgren-Lawrence (KL) score, Body Mass Index (BMI), oral salmon calcitonin (sCT) treatment and diurnal variation

Biochemical markers and the FDA Critical Path: How biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development

(2009) M.A. Karsdal et al.   BIOMARKERS

Influence of food intake on the bioavailability and efficacy of oral calcitonin

(2009) Morten A. Karsdal et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

A Pharmacokinetic and Pharmacodynamic Comparison of Synthetic and Recombinant Oral Salmon Calcitonin

(2009) Morten A. Karsdal et al.   JOURNAL OF CLINICAL PHARMACOLOGY

The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study

(2009) M.A. Karsdal et al.   OSTEOARTHRITIS AND CARTILAGE

Osteoarthritis

(2008) Siddharth Kumar Das et al.   BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Osteoclasts secrete non-bone derived signals that induce bone formation

(2008) Morten A. Karsdal et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Calcitonin ??? A Drug of the Past or for the Future?

(2008) Morten A Karsdal et al.   BIODRUGS

Tibolone inhibits bone resorption without secondary positive effects on cartilage degradation

(2008) MA Karsdal et al.   BMC MUSCULOSKELETAL DISORDERS

Biochemical Markers for Monitoring Response to Therapy: Evidence for Higher Bone Specificity by a Novel Marker Compared with Routine Markers

(2008) D. J. Leeming et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Should subchondral bone turnover be targeted when treating osteoarthritis?

(2008) M.A. Karsdal et al.   OSTEOARTHRITIS AND CARTILAGE